Eupraxia Pharmaceuticals (EPRX) Share-based Compensation (2023 - 2026)
Eupraxia Pharmaceuticals' Share-based Compensation came in at $3.03 million for the quarter ended Jun 30, 2026, up 171.4% from $1.12 million a year earlier and up 34.6% from the prior quarter.
Eupraxia Pharmaceuticals (EPRX) Share-based Compensation (2023 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Eupraxia Pharmaceuticals reported Share-based Compensation of $11.43 million, up 175.7% year-over-year; for the year ended Dec 31, 2025, it was $8.76 million, up 171.6% from the prior year.
- Share-based Compensation carries a three-year compound annual growth rate of 82.8% (years ended Dec 2022 to Dec 2025).
- Going back by year, Share-based Compensation was $3.22 million in the year ended Dec 31, 2024 (+128.2%), $1.41 million in the year ended Dec 31, 2023 (-1.5%) and $1.43 million in the year ended Dec 31, 2022.
- The five-year range for quarterly Share-based Compensation is $213,130 (the quarter ended Mar 31, 2024) to $5.7 million (the quarter ended Dec 31, 2025).
- Year-over-year, Share-based Compensation has increased for three consecutive quarters, with growth averaging 189.3% over the last eight quarters.
- The fastest year-over-year change in Share-based Compensation over five years came in the quarter ended Mar 31, 2025 (growth of 600.7%), and the weakest in the quarter ended Mar 31, 2024 (a decline of 32.9%).
- Business Quant data shows EPRX's Share-based Compensation at $2.25 million (quarter ended Mar 31, 2026), $5.7 million (quarter ended Dec 31, 2025) and $446,106 (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Eupraxia Pharmaceuticals | 328.04 Mn | 326.44 Mn | - | 3.03 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.03 Mn |
| Mar 31, 2026 | 2.25 Mn |
| Dec 31, 2025 | 5.70 Mn |
| Sep 30, 2025 | 446,106.00 |
| Jun 30, 2025 | 1.12 Mn |
| Mar 31, 2025 | 1.49 Mn |
| Dec 31, 2024 | 1.03 Mn |
| Sep 30, 2024 | 507,246.00 |
| Jun 30, 2024 | 1.47 Mn |
| Mar 31, 2024 | 213,130.00 |
| Dec 31, 2023 | 309,844.00 |
| Sep 30, 2023 | 358,875.00 |
| Jun 30, 2023 | 426,118.00 |
| Mar 31, 2023 | 317,420.00 |
Eupraxia Pharmaceuticals Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=EPRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "EPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=EPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();